Individual AD patients will likely have their own distinct pattern of toxic protein variants of Aβ, tau, and TDP-43 and as neurodegeneration progresses and spreads to different brain regions, each patient’s protein variant fingerprint will likely change. Here, MAPT is linked to Alzheimer disease.